Microport Cardioflow Medtech Corp
HKEX:2160
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Microport Cardioflow Medtech Corp
Retained Earnings
Microport Cardioflow Medtech Corp
Retained Earnings Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Microport Cardioflow Medtech Corp
HKEX:2160
|
Retained Earnings
-¥2.3B
|
CAGR 3-Years
-112%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Retained Earnings
¥2.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
56%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Retained Earnings
¥10.6B
|
CAGR 3-Years
17%
|
CAGR 5-Years
19%
|
CAGR 10-Years
22%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Retained Earnings
¥30.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Retained Earnings
¥19.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
138%
|
CAGR 10-Years
107%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Retained Earnings
¥5.6B
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Microport Cardioflow Medtech Corp
Glance View
MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-02-04. The firm is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The firm's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The firm mainly conducts business within the domestic market.
See Also
What is Microport Cardioflow Medtech Corp's Retained Earnings?
Retained Earnings
-2.3B
CNY
Based on the financial report for Dec 31, 2025, Microport Cardioflow Medtech Corp's Retained Earnings amounts to -2.3B CNY.
What is Microport Cardioflow Medtech Corp's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-21%
Over the last year, the Retained Earnings growth was 0%. The average annual Retained Earnings growth rates for Microport Cardioflow Medtech Corp have been -112% over the past three years , -21% over the past five years .
